CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 414 filers reported holding CRISPR THERAPEUTICS AG in Q4 2020. The put-call ratio across all filers is 1.10 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $425,440 | +6.8% | 9,373 | +32.0% | 0.00% | 0.0% |
| Q2 2023 | $398,538 | +23.5% | 7,099 | -0.5% | 0.00% | +50.0% |
| Q1 2023 | $322,671 | +5.3% | 7,134 | -5.4% | 0.00% | 0.0% |
| Q4 2022 | $306,420 | -35.2% | 7,538 | +4.2% | 0.00% | -66.7% |
| Q3 2022 | $473,000 | -1.9% | 7,232 | -8.8% | 0.01% | 0.0% |
| Q2 2022 | $482,000 | -9.4% | 7,932 | -6.5% | 0.01% | 0.0% |
| Q1 2022 | $532,000 | +14.9% | 8,482 | +38.7% | 0.01% | 0.0% |
| Q4 2021 | $463,000 | -61.4% | 6,115 | -43.0% | 0.01% | -62.5% |
| Q3 2021 | $1,201,000 | +88.2% | 10,733 | +172.1% | 0.02% | +77.8% |
| Q2 2021 | $638,000 | +74.3% | 3,944 | +31.2% | 0.01% | +12.5% |
| Q1 2021 | $366,000 | -55.0% | 3,006 | -43.5% | 0.01% | -57.9% |
| Q4 2020 | $814,000 | +50.2% | 5,317 | -18.0% | 0.02% | +35.7% |
| Q3 2020 | $542,000 | +13.4% | 6,483 | -0.3% | 0.01% | +7.7% |
| Q2 2020 | $478,000 | +136.6% | 6,503 | +36.8% | 0.01% | +85.7% |
| Q1 2020 | $202,000 | -40.8% | 4,752 | -14.7% | 0.01% | -22.2% |
| Q4 2019 | $341,000 | +53.6% | 5,573 | +17.5% | 0.01% | +28.6% |
| Q2 2019 | $222,000 | -57.6% | 4,743 | -60.1% | 0.01% | -61.1% |
| Q3 2018 | $523,000 | -2.4% | 11,873 | +30.8% | 0.02% | -33.3% |
| Q2 2018 | $536,000 | – | 9,080 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 498,558 | $27,989,046 | 33.20% |
| Gilfoyle Management LLC | 100 | $4,842 | 15.90% |
| NEA Management Company, LLC | 1,587,854 | $89,142,124 | 6.80% |
| ARK Investment Management | 7,338,447 | $411,980,394 | 2.73% |
| Nikko Asset Management Americas, Inc. | 3,533,357 | $198,327,328 | 2.09% |
| Del-Sette Capital Management, LLC | 33,661 | $1,889,729 | 1.79% |
| Ikarian Capital, LLC | 200,000 | $11,228,000 | 1.79% |
| Ikarian Capital, LLC | 200,000 | $11,228,000 | 1.79% |
| Merlin Capital, Inc | 8,802 | $494,144 | 1.67% |
| Green Alpha Advisors, LLC | 34,373 | $1,929,700 | 1.27% |